Skip to main content
. 2020 Jan 13;2020(1):CD012643. doi: 10.1002/14651858.CD012643.pub3

Cocorocchio 2009.

Notes Title: Prognostic role of interim 18FDG‐PET in Hodgkin lymphoma: A single‐center experience.
(Conference abstract)
Aim

  • Single‐centre experience with using 18FDG‐PET as a prognostic factor for long term complete remission (CR)


Study design

  • Retrospective


Country/treatment centre(s)

  • Italy


Number of included participants

  • 65


Inclusion criteria

  • Newly diagnosed with HL


Exclusion criteria

  • Not reported


Treatment

  • VBM or ChlVPP/ABVVP followed by IFRT


Primary outcome measure(s)

  • Complete remission

  • Freedom from treatment failure